s-1/cpt-11/cetuximab combination therapy in patients with advanced colorectal kras wild cancer: phase 2 trial

s-1/cpt-11/cetuximab combination therapy in patients with advanced colorectal kras wild cancer: phase 2 trial - iris/cet combination phase 2 trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000006059

Enrollment

Registered

2011-07-29

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

advanced colorectal kras-wild cancer

Interventions

ts-1 cpt-11 cetuximab

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: advanced colorectal kras-wild cancer

Exclusion criteria

Exclusion criteria: double cancer

Design outcomes

Primary

Measure	Time frame
response rate	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026